Table: Shin Nippon Biomedical -2019/20 group results

Shin Nippon Biomedical Laboratories

11/05/2020 07:00

May 11 (Reuters)- 
          Shin Nippon Biomedical Laboratories Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           14.56           15.66          14.81         6.91    
               (-7.0 pct)      (-5.7 pct)     (+1.7 pct)    (+8.2 pct) 
  Operating        2.23          829 mln          1.80       700 mln   
              (+168.5 pct)                    (-19.2 pct)  (-35.1 pct) 
  Recurring        3.12            1.61           2.20       900 mln   
               (+93.4 pct)                    (-29.5 pct)  (-28.5 pct) 
  Net
  Net              2.55            1.95           1.80       700 mln   
               (+30.8 pct)                    (-29.4 pct)  (-20.2 pct) 
  EPS           61.25 yen       46.84 yen      43.23 yen    16.81 yen  
  Ann Div       5.00 yen        3.00 yen       5.00 yen                
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       5.00 yen        3.00 yen       5.00 yen                
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T